Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.9 (
glucose-6-phosphatase
)
3,081
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The classical role of
glucose-6-phosphatase
in liver and kidney is the production of glucose for release into blood. In liver,
glucose-6-phosphatase
catalyses the terminal step of glycogenolysis and gluconeogenesis. Abnormally low hepatic
glucose-6-phosphatase
activity is found in human genetic deficiencies i.e. glycogen storage disease type I and in cases of
developmental delay
, found predominantly in preterm infants. In contrast, abnormally high liver
glucose-6-phosphatase
occurs in poorly controlled or untreated diabetes mellitus. Hepatic
glucose-6-phosphatase
is an integral endoplasmic reticulum (and nuclear membrane) protein and it is part of a multicomponent system. Its active site is situated inside the lumen of the endoplasmic reticulum and transport proteins are needed to allow its substrates glucose-6-phosphate (and pyrophosphate) and its products phosphate and glucose to cross the endoplasmic reticulum membrane. In addition, a calcium binding protein is also associated with the
glucose-6-phosphatase
enzyme. Immunohistochemical studies, in combination with image analysis, have shown that
glucose-6-phosphatase
is present in liver and kidney and also in specific cell types in a variety of human tissues, for example Leydig cells in the testis and some astrocytes in the brain. Where practicable, enzymatic analysis, direct transport assays and/or immunological detection of the endoplasmic reticulum glucose and phosphate transport proteins have been used to demonstrate the presence and activity of the whole
glucose-6-phosphatase
system. The distribution of the human
glucose-6-phosphatase
system changes dramatically during development with a different spatial and temporal pattern in each tissue. The most unexpected localization was in circulating, predominantly nucleated, embryonic and early fetal red blood cells.
...
PMID:The glucose-6-phosphatase system in human development. 857 17